US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

83.25

+2.272.80%

Post-market: 84.140.8900+1.07%19:59 EDT

Volume:174.93K

Turnover:14.56M

Market Cap:25.81M

PE:- -

High:86.87

Open:82.50

Low:79.75

Close:80.98

52wk High:143.84

52wk Low:14.95

Shares:310.00K

Float Shares:310.00K

Volume Ratio:1.04

T/O Rate:56.43%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million

Cboe data shows mixed options sentiment in Moderna with shares down 2.14%

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Scholar Rock announces FDA approval of isembyld

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Pharming wins FDA nod to extend Joenja use to younger APDS children

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

Moderately bullish activity in Moderna with shares up 8.03%

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

Walvax Biotechnology's Subsidiary Secures Regulatory Approval for COVID-19 mRNA Vaccine

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live

Moderately bullish activity in Moderna with shares down 1.79%

The Second Act of Biotech

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/MRNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":83.25,"timestamp":1789588800000,"preClose":80.98,"halted":0,"volume":174931,"hourTrading":{"tag":"盘后","latestPrice":84.14,"preClose":83.25,"latestTime":"19:59 EDT","volume":2364,"amount":197490.4251,"timestamp":1789603180978,"change":0.89,"changeRate":0.010691,"amplitude":0.028589},"delay":0,"changeRate":0.028031612743887328,"floatShares":310000,"shares":310000,"eps":0,"marketStatus":"Closed","change":2.27,"latestTime":"09-16 16:00:00 EDT","open":82.5,"high":86.8694,"low":79.75,"amount":14561265.186549999,"amplitude":0.087916,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":80.98,"sharesOutstanding":30000,"nav":81.19,"aum":22733200,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":83.4,"preClose":80.98,"latestTime":"09:27 EDT","volume":624,"amount":51465.966239999994,"timestamp":1789565247726,"change":2.42,"changeRate":0.029884,"amplitude":0.035441},"postHourTrading":{"tag":"盘后","latestPrice":84.14,"preClose":83.25,"latestTime":"19:59 EDT","volume":2364,"amount":197490.4251,"timestamp":1789603180978,"change":0.89,"changeRate":0.010691,"amplitude":0.028589},"volumeRatio":1.036268,"impliedVol":1.3179,"impliedVolPercentile":0.2667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":310000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.036268,"shares":310000,"dividePrice":0,"high":86.8694,"amplitude":0.087916,"preClose":80.98,"low":79.75,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":83.25,"eps":0,"divideRate":0,"volume":174931,"delay":0,"ttmEps":0,"open":82.5,"prevYearClose":20.61,"prevWeekClose":81.41,"prevMonthClose":79.5,"prevQuarterClose":42.65,"fiveDayClose":72.66,"twentyDayClose":31.33,"sixtyDayClose":31.4256},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668109935","title":"Moderna President Stephen Hoge Disposes of 80,575 Common Shares Worth $11.78 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668109935","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668109935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:49","pubTimestamp":1789591761,"startTime":"0","endTime":"0","summary":"Moderna President Stephen Hoge disposes of 80,575 common shares worth $11.78 millionModerna President Stephen Hoge cut his direct common-stock stake to 1,562,029 shares via option exercises, then sale","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL32Fyc6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4534","BK4532","LGHT","MRNX","BK4533","BK4588","BK4548","BK4551","WDNA","IDNA","GNOM","BK4139","BK4501","MRNA","MRNY","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667214586","title":"Cboe data shows mixed options sentiment in Moderna with shares down 2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667214586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667214586?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:50","pubTimestamp":1789498212,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares down $3.15 near $143.54. Options volume relatively light with 39k contracts ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-2-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-2-14-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","WDNA","MRNX","BK4501","BK4548","GNOM","IDNA","BK4568","MRNY","MRNA","BK4139","BK4534","BK4533","BK4585","BK4551","LGHT","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["BK4585","IDNA","MEDI","GNMX","TECB","XLVX","FRTY","TBXU","LABU","XBIX","IBB","RSPH","GDOC","IYH","MRNY","PSCH","SYNB","BMED","PINK","BK4588","NVIB","BBP","LFSC","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695518","title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695518","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695518?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:25","pubTimestamp":1789417559,"startTime":"0","endTime":"0","summary":"Moderna CFO James M. Mock disposes of 34,836 common shares worth $4.68 millionModerna CFO Mock James M disclosed sales of 34,836 common shares on Sep. 10, 2026 at USD 134.49.He also exercised stock op","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL8rXTDg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4551","MRNX","WDNA","GNOM","MRNY","BK4585","BK4534","LGHT","BK4139","BK4588","MRNA","BK4533","BK4548","BK4568","BK4532","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","MRNY","IEIH","LABU","GNMX","TECB","IYH","GDOC","BK4007","PSCH","PINK","SYNB","BFRI","NVIB","LFSC","BMED","TBXU","IDNA","BK4585","BBP","MRNX","XLVX","RSPH","BK4588","FRTY","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","MRNX","IBB","GDOC","LFSC","IYH","TBXU","LABU","IDNA","GNMX","BBP","FRTY","BMED","IEIH","RSPH","PSCH","PINK","XLVX","BK4588","TECB","BK4585","MRNY","SYNB","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BMED","GNMX","LABU","TECB","MRNX","IYH","BK4139","PINK","IBRN","IBB","RSPH","TBXU","THNR","LFSC","BK4588","MEDI","SRRK","IDNA","PSCH","BBP","FRTY","BK4585","GDOC","IEIH","NVIB","MRNY","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4588","MRNY","IEIH","IYH","BMED","TECB","BK4179","BK4585","IDNA","MRNX","XLVX","LABU","PINK","LFSC","NVIB","TLX","MEDI","PSCH","GDOC","GNMX","RSPH","FET","BK4139","IBB","TBXU","SYNB","FRTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","THNR","BBP","MRNY","LFSC","IEIH","RSPH","IBB","GDOC","BK4588","TBXU","MRNX","IBRN","LABU","SYNB","BMED","PSCH","SRRK","NVIB","MEDI","TECB","GNMX","BK4139","FRTY","IYH","XLVX","IDNA","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","LU0109394709.USD","LU0058720904.USD","LU0861579265.USD","BK4588","LU1674673691.USD","BMED","LU0114720955.EUR","MRNX","TBXU","LU1571399168.USD","LU1585245621.USD","BK4548","IBB","MEDI","LU1430594728.SGD","LU1934455277.USD","GILD","LU1674673428.USD","LU0965509101.SGD","IDNA","SG9999015986.USD","BK4578","IE00BKVL7J92.USD","IE00B19Z3581.USD","TMED","LU0289739699.SGD","LU2468319806.SGD","MRNA","SG9999015952.SGD","LU0889565916.HKD","LGHT","BBH","MRNY","BK4534","LU1778281490.HKD","IBBQ","LU1066051498.USD","GNOM","BK4139","LU2357627491.SGD","IE00B3T34201.USD","BIB","LU0965508806.USD","LU1057294990.SGD","LU0965509010.AUD","BK4568","SG9999015978.USD","LU0965509283.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","GDOC","FRTY","NVIB","BK4588","LABU","IDNA","RSPH","BMED","BBP","MRNX","BK4585","GNMX","PINK","MEDI","IEIH","IBB","MRNY","TBXU","XLVX","SYNB","PSCH","TECB","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575576","title":"Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575576","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:15","pubTimestamp":1789146928,"startTime":"0","endTime":"0","summary":"• Moderna experienced upward volatility driven by renewed institutional buying and consolidation.\n• Phase 3 trial results for intismeran autogene validated its oncology platform.\n• Latest annual revenue is $1.94B with a net loss of $-2.82B.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262164027-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4548","BK4533","BK4551","GNOM","LGHT","BK4568","IDNA","MRNA","BK4532","MRNY","WDNA","BK4139","MRNX","BK4501","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666576334","title":"Moderately bullish activity in Moderna with shares up 8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666576334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666576334?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:00","pubTimestamp":1789146015,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares up $10.97, or 8.03%, near $147.59. Options volume roughly in line with average with 139k...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-8-03-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-8-03-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","BK4548","BK4533","BK4551","GNOM","LGHT","BK4568","IDNA","MRNA","BK4532","MRNY","WDNA","BK4139","MRNX","BK4501","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666573009","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2666573009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666573009?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:00","pubTimestamp":1789142409,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeDell Technologies IncDELL.N+11.0%Hewlett Packard Enterprise CompanyHPE.N+9.1%Skyworks Solutions, Inc.SWKS.OQ+8.1%Moderna, Inc.MRNA.OQ+8.1%Flex LtdFLEX.OQ+7.8%Bottom PerformersPercent ChangeSeagate Technology Holdings PLCSTX.OQ-3.6%Baker Hughes CompanyBKR.OQ-3.1%SanDisk CorporationSNDK.OQ-3.1%The Clorox CompanyCLX.N-2.9%Palo Alto Networks, Inc.PANW.OQ-2.6%As of 12:00 p.m., the S&P 500.SPXgained 78.63 points, or 1.04%, to 7,670.33 and had posted 7 new 52-week highs and 6 new lows.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4531EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171311.SGD","BK4605","LU0011850046.USD","PTF","VOO","LU1861215975.USD","BK4533","LU0081259029.USD","HIBS","ETFT","BMAY","LU0211326839.USD","LU0266013472.USD","IE00B19Z3B42.SGD",".SPX","BK4585","SG9999001424.SGD","ITOT","IHAK","LU2473716301.USD","DELL","LU1119994496.HKD","BK4551","LU2210149790.SGD","SPXS","XLG","BK4170","LU0225284248.USD","LU0496365809.HKD","BK4097","BK4581","QQQG","VTV","LU1983260115.SGD","BK4145","LU0057025933.USD","LU2125909916.SGD","LU1303367103.USD","SPYG","TSPY","IE00B19Z8X17.USD","LU0082616367.USD","LU0976567544.SGD","LU2463526074.USD","LU0124676726.USD","FSMD","LU2244417387.USD","LU2106854487.HKD","LU2065169927.USD","LU2286300806.USD","VV","LU1169590202.USD","LGHT","IEZ","CIBR","LU1169589451.USD","BK4515","BK4548","IJR","LU1974910355.USD","LU1046421795.USD","LU1670627923.USD","SPAM","LU1720051017.SGD","LU0289961442.SGD","LU0289960550.SGD","LU2322448791.USD","SNDK","VBK","SPLV","LU0345770993.USD","IE00BN0W2W23.USD","DISK","LU0472753341.HKD","SPYQ","SNDC","IE00B7SZLL34.SGD","LU1235294995.USD","LU0742534661.SGD","IDNA","PALD","SPY","XDTE","WCBR","LU1720051108.HKD","LU0719512351.SGD","LU0963586101.USD","SPGP","LU0154245673.USD","PXJ","LU1084165304.USD","LU1861220033.SGD","LU2065171402.SGD","BK4018","LU0187121727.USD","LU1989764748.USD","ACWI","FLEL","JEPI","IE00BMPRXN33.USD","BK4568","MRNA","LU2210150020.SGD","SCHB","LU2272731782.SGD","LU0154245756.USD","LU1366192091.USD","PANW","VEU","WLDR","UPRO","SPHD","LU1712237335.SGD","LU0208291251.USD","IE00BN0W2T93.GBP","LU0823421416.USD","SSO","LU1989764664.SGD","IVE","BK4560","LU0234570918.USD","PSWD","LU0211326755.USD","LU0689626769.HKD","LU2272731600.USD","EGGY","SNDQ","SPYH","LU1670628061.USD","IE0002270589.USD","OIH","LU1992135399.USD","LU0348723411.USD","LU1548497426.USD","LU1804176565.USD","LU2095319765.USD","IE00BMPRXR70.SGD","LU0070302665.USD","BK4532","IVV","LU2543165471.USD","SDS","DRMY","SMAX","LU1623119135.USD","SCHA","SWKS","BK4534","YSPY","LU1267930227.SGD","RULE","LU2272731865.HKD","LU2355687059.USD","BK4504","LU0251131958.USD","HPE","LU0203345920.USD","MRNY","LU0052756011.USD","SPHQ","BK4139","IE00B19Z8W00.USD","BK4535","LU2290526834.HKD","SPYU","VOOG","CLX","LU0256331488.USD","BUG","IE00B19Z9Z06.USD","LU0267386448.USD","LU0128525689.USD","GNOM","LU1571399168.USD","BK4512","IE00BN0W2V16.EUR","LU2098885051.SGD","LU1153585028.USD","LU0823434583.USD","LU0321505439.SGD","VTI","MRNX","LU0054578231.USD","TMSL","LU2023250843.SGD","LU0048573561.USD","QQQA","LU0069063385.USD","LU0006061336.USD","BK4550","LU2125909759.SGD","LU2265009873.SGD","SPUS","PALU","XYLD","DBSC","LU0306806265.USD","SPUU","WCLD","MMAX","LU0306807586.USD","FXL","IGV","LU2023250504.SGD","IE00B19Z3581.USD","LU0310800965.SGD","BK4567","HAKY","IE00BZ1G4Q59.USD","BK4501","IVW","NOBL","STXX","LU0320765489.SGD","IJH","MOAT","BK4179","SCHX","GSLC","LU1823568750.SGD","RSPU","SH","BK4141","LU0823434740.USD","BK4588","HPEL","LU1261432733.SGD","AIFD","RSPN","IE00B19Z9505.USD","SPYV","LU0203347892.USD","GPIX","LU0251142724.SGD","LU0345770308.USD","LU0511384066.AUD","BK4543","LU0823421333.USD","IE00BKVL7J92.USD","BK4554","LU1992135472.HKD","DLLL","LU0985481810.HKD","LU2360107168.USD","SCHM","SNXX","DMAX","OPTZ","STXL","LU0289739343.SGD","SNDU","LU0175139822.USD","RSP","FCUS","SPDN","SPXU","SPYD","ALLW","WDNA","FLEX","LU1923622291.USD","BK4598","COWG","PANG","LU0211331839.USD","CNAV","SPMO","SPYM","LU2065170008.USD","SNDG","LU0321505868.SGD","LU2322448957.HKD","RSPA","CLOD","LU1917777945.USD","SFY","HIBL","BK4566","STX","SPXL","STXU","BKR","IE00B19Z9P08.USD","IE00B894F039.SGD","LU0225771236.USD","LU2063271972.USD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529289","title":"Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529289","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529289?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125772,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $112.72, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IDNA","MRNY","WDNA","BK4548","BK4534","BK4568","BK4532","BK4501","BK4588","GNOM","MRNA","BK4533","BK4139","LGHT","BK4551","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666422435","title":"Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666422435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666422435?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:20","pubTimestamp":1789114812,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moderna (MRNA), Merck & Company (MRK) and Pacific ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","IE0009355771.USD","MRNY","WDNA","LU1941712264.USD","LU1066051225.USD","LU0859254822.USD","BK4550","LU0238689110.USD","BK4121","LU2125154935.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU2324357040.USD","LU2491050071.SGD","LU1989772923.USD","LU0965509101.SGD","LU0058720904.USD","LU2112291526.USD","LU2125909247.SGD","BK4516","IHE","LU2361045086.USD","LU1066051498.USD","LU1037948541.HKD","LU0985320562.USD","LU1201861249.SGD","IDNA","MRNA","LU1023059063.AUD","IYH","LU1116320901.HKD","LU0868494708.USD","LU0266013472.USD","BK4139","IE00B2B36J28.USD","LU0980610538.SGD","PACB","IE00BSNM7G36.USD","BK4501","LU0965509010.AUD","SG9999002232.USD","BK4568","LU1934455863.HKD","BK4534","LU0130517989.USD","SG9999001440.SGD","LU1291159041.SGD","PPH","LU1929549753.HKD","LU1699723380.USD","LU1941712348.USD","IE00BLSP4239.USD","GNOM","SG9999014567.USD","LU2125154778.USD","GDOC","LU1917777945.USD","SG9999002224.SGD","BK4532","LU0203347892.USD","LU0477156953.USD","LU0106261372.USD","VHT","LU0689626769.HKD","LU1989771016.USD","LU2491050154.USD","LU0320765646.SGD","RXL","LU0432979614.USD","IXJ","LU1037948897.HKD","LU1585245621.USD","LU0130102774.USD","LU2357627491.SGD","LU0006306889.USD","LU0203345920.USD","SG9999001176.USD","IE00BBT3K403.USD","LU0070302665.USD","LU1934455277.USD","LU0265550946.USD","BK4007","LU2361044949.HKD","LU2125909593.SGD","LU1057294990.SGD","LU1093756168.USD","LU0965509283.SGD","LU0211331839.USD","LU1162221912.USD","BK4551","LU1069347547.HKD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU1974910355.USD","BK4585","LU1983299246.USD","LU1093756325.SGD","LU1116320737.USD","LGHT","JDOC","LU0208291251.USD","LU2360032135.SGD","BK4548","LU1430594728.SGD","LU0234572021.USD","SG9999001176.SGD","BK4533","LU1923622614.USD","HRTS","BK4588","IE00BJJMRZ35.SGD","LU0861579265.USD","LU1032466523.USD","LU1035773651.USD","FHLC","IE0002141913.USD","LU0122379950.USD","MRK","LU2089984988.USD","LU0124676726.USD","LU2023250843.SGD","SG9999014575.USD","LU1989772840.SGD","LU2433249047.HKD","TRUH","LU2023250504.SGD","LU1066053197.SGD","LU1061106388.HKD","LU2461242641.AUD","MRNX","LU2106854487.HKD","PAWZ","SG9999014559.SGD","LU2491049909.HKD","SG9999015341.SGD","LU0265550359.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","BK4559","LU0942090050.USD","IE00B4R5TH58.HKD","LU0098860793.USD","LU2468319806.SGD","FTXH","LU0648001328.SGD","SG9999013999.USD","LU2361044865.SGD","LU0320765489.SGD","LU0823416689.USD","LU1066051811.HKD","LU1934455194.USD","SG9999014542.SGD","LU1571399168.USD","SG9999015358.SGD","IE00BN8TJ469.HKD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158588840","title":"Walvax Biotechnology's Subsidiary Secures Regulatory Approval for COVID-19 mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1158588840","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158588840?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:08","pubTimestamp":1789045687,"startTime":"0","endTime":"0","summary":"Walvax Biotechnology Co.,Ltd. (300142.SZ) has officially announced that its wholly-owned subsidiary, Yuxi Walvax Biotechnology Co., Ltd., received the \"COVID-19 mRNA Vaccine\" Drug Registration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0046","MRNX","MRNY","300142","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311265","title":"Moderna Set for 3 Near-Term INT Data Readouts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311265","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311265?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:58","pubTimestamp":1788969505,"startTime":"0","endTime":"0","summary":"Moderna  is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Securities said in a Tuesday note.The next major catalyst is the release of phase 3 data on melanoma at an international conference this fall, investors awaiting efficacy on recurrence-free survival and distant metastasis-free survival, the brokerage said.Likely to follow is the phase 2 data on either renal cell carcinoma or muscle-invasive bladder cancer, potentially in 2027, according to UBS. The next readout is probably a phase 3 update on adjuvant non-small cell lung cancer, the investment firm added.UBS has a neutral rating and $150 price target on Moderna.Price: 137.50, Change: -2.83, Percent Change: -2.02","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IDNA","MRNY","WDNA","BK4548","BK4534","BK4568","BK4532","BK4501","BK4588","GNOM","MRNA","BK4533","BK4139","LGHT","BK4551","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372326","title":"Moderately bullish activity in Moderna with shares down 1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:20","pubTimestamp":1788891611,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares down $2.60 near $142.95. Options volume relatively light with 44k contracts traded and c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-1-79-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-1-79-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","MRNY","BK4532","BK4139","MRNA","BK4588","BK4534","WDNA","GNOM","BK4533","IDNA","LGHT","MRNX","BK4551","BK4585","BK4501","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665531933","title":"The Second Act of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2665531933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665531933?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:08","pubTimestamp":1788779310,"startTime":"0","endTime":"0","summary":"Pfizer sells dopamine. Moderna made the COVID vaccine. Both are betting their next decade on medicines that barely existed when their stocks peaked...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225771236.USD","SG9999001176.SGD","BK4533","IE00B19Z3581.USD","SG9999013999.USD","BK4501","MRNY","IE00B19Z3B42.SGD","SG9999001176.USD","BK4551","BK4568","SG9999011175.SGD","LGHT","LU1057294990.SGD","LU1894683264.USD","LU0456855351.SGD","BK4548","BK4534","IE00B3T34201.USD","LU0289739699.SGD","LU0122379950.USD","BK4532","SG9999003800.SGD","LU1883839398.USD","IE0002270589.USD","MRNA","BK4550","BK4588","LU0306807586.USD","BK4581","LU1023059063.AUD","GNOM","BK4599","PFE","SG9999002224.SGD","IDNA","SG9999002232.USD","SGXZ57979304.SGD","BK4007","BK4592","LU0234572021.USD","OZEM","IE00BLSP4452.SGD","LU0306806265.USD","LU1066051498.USD","IE00BLSP4239.USD","LU0170899867.USD","BK4585","LU0868494617.USD","IE00BBT3K403.USD","LU2596442595.SGD","MRNX","LU0321505868.SGD","LU0321505439.SGD","LU1894683348.USD","LU0058720904.USD","IE000M9KFDE8.USD","LU1066053197.SGD","WDNA","BK4139","LU0985481810.HKD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}